| Vaccine efficacy of ALVAC-HIV and bivalent subtype c gp120–MF59 in adults GE Gray, LG Bekker, F Laher, M Malahleha, M Allen, Z Moodie, ... New England Journal of Medicine 384 (12), 1089-1100, 2021 | 266 | 2021 |
| PrEP uptake, persistence, adherence, and effect of retrospective drug level feedback on PrEP adherence among young women in southern Africa: Results from HPTN 082, a randomized … C Celum, S Hosek, M Tsholwana, S Kassim, S Mukaka, BJ Dye, S Pathak, ... PLoS medicine 18 (6), e1003670, 2021 | 188 | 2021 |
| Pharmacokinetics of isoniazid, pyrazinamide, and ethambutol in newly diagnosed pulmonary TB patients in Tanzania P Denti, K Jeremiah, E Chigutsa, D Faurholt-Jepsen, G PrayGod, ... PloS one 10 (10), e0141002, 2015 | 135 | 2015 |
| Pharmacokinetics of efavirenz and treatment of HIV-1 among pregnant women with and without tuberculosis coinfection KE Dooley, P Denti, N Martinson, S Cohn, F Mashabela, J Hoffmann, ... The Journal of infectious diseases 211 (2), 197-205, 2015 | 108 | 2015 |
| Pharmacokinetics of rifampin, isoniazid, pyrazinamide, and ethambutol in infants dosed according to revised WHO-recommended treatment guidelines A Bekker, HS Schaaf, HR Draper, L van der Laan, S Murray, L Wiesner, ... Antimicrobial agents and chemotherapy 60 (4), 2171-2179, 2016 | 100 | 2016 |
| Progress towards the UNAIDS 90–90-90 goals by age and gender in a rural area of KwaZulu-Natal, South Africa: a household-based community cross-sectional survey H Huerga, G Van Cutsem, J Ben Farhat, A Puren, M Bouhenia, L Wiesner, ... BMC public health 18 (1), 303, 2018 | 96 | 2018 |
| Pharmacokinetics and safety of moxifloxacin in children with multidrug-resistant tuberculosis S Thee, AJ Garcia-Prats, HR Draper, HM McIlleron, L Wiesner, S Castel, ... Clinical Infectious Diseases 60 (4), 549-556, 2015 | 96 | 2015 |
| Drug–drug interactions between bedaquiline and the antiretrovirals lopinavir/ritonavir and nevirapine in HIV-infected patients with drug-resistant TB M Pandie, L Wiesner, H McIlleron, J Hughes, S Siwendu, F Conradie, ... Journal of Antimicrobial Chemotherapy 71 (4), 1037-1040, 2016 | 81 | 2016 |
| UCT943, a next-generation Plasmodium falciparum PI4K inhibitor preclinical candidate for the treatment of malaria C Brunschwig, N Lawrence, D Taylor, E Abay, M Njoroge, GS Basarab, ... Antimicrobial agents and chemotherapy 62 (9), 10.1128/aac. 00012-18, 2018 | 80 | 2018 |
| Nutritional supplementation increases rifampin exposure among tuberculosis patients coinfected with HIV K Jeremiah, P Denti, E Chigutsa, D Faurholt-Jepsen, G PrayGod, ... Antimicrobial agents and chemotherapy 58 (6), 3468-3474, 2014 | 80 | 2014 |
| Efficacy and safety of artemether–lumefantrine, artesunate–amodiaquine, and dihydroartemisinin–piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in … E Davlantes, PR Dimbu, CM Ferreira, M Florinda Joao, D Pode, J Félix, ... Malaria journal 17 (1), 144, 2018 | 79 | 2018 |
| Clofazimine pharmacokinetics in patients with TB: dosing implications MT Abdelwahab, S Wasserman, JCM Brust, NR Gandhi, G Meintjes, ... Journal of Antimicrobial Chemotherapy 75 (11), 3269-3277, 2020 | 77 | 2020 |
| Incentives conditioned on tenofovir levels to support PrEP adherence among young South African women: a randomized trial CL Celum, K Gill, JF Morton, G Stein, L Myers, KK Thomas, M McConnell, ... Journal of the International AIDS Society 23 (11), e25636, 2020 | 77 | 2020 |
| Interaction between artemether-lumefantrine and nevirapine-based antiretroviral therapy in HIV-1-infected patients T Kredo, K Mauff, JS Van der Walt, L Wiesner, G Maartens, K Cohen, ... Antimicrobial agents and chemotherapy 55 (12), 5616-5623, 2011 | 75 | 2011 |
| Tenofovir diphosphate concentrations in dried blood spots from pregnant and postpartum adolescent and young women receiving daily observed pre-exposure prophylaxis in sub … L Stranix-Chibanda, PL Anderson, D Kacanek, S Hosek, S Huang, ... Clinical Infectious Diseases 73 (7), e1893-e1900, 2021 | 74 | 2021 |
| Acceptability, safety, and patterns of use of oral tenofovir disoproxil fumarate and emtricitabine for HIV pre-exposure prophylaxis in South African adolescents: an open-label … K Gill, L Johnson, J Dietrich, L Myer, R Marcus, M Wallace, T Pidwell, ... The Lancet Child & Adolescent Health 4 (12), 875-883, 2020 | 73 | 2020 |
| Safety, Tolerability, Pharmacokinetics, and Antimalarial Activity of the Novel Plasmodium Phosphatidylinositol 4-Kinase Inhibitor MMV390048 in Healthy Volunteers P Sinxadi, C Donini, H Johnstone, G Langdon, L Wiesner, E Allen, ... Antimicrobial agents and chemotherapy 64 (4), 10.1128/aac. 01896-19, 2020 | 69 | 2020 |
| Improved antiparasitic activity by incorporation of organosilane entities into half-sandwich ruthenium (II) and rhodium (III) thiosemicarbazone complexes M Adams, C de Kock, PJ Smith, KM Land, N Liu, M Hopper, A Hsiao, ... Dalton Transactions 44 (5), 2456-2468, 2015 | 67 | 2015 |
| Synthesis and evaluation of hybrid drugs for a potential HIV/AIDS-malaria combination therapy MN Aminake, A Mahajan, V Kumar, R Hans, L Wiesner, D Taylor, ... Bioorganic & medicinal chemistry 20 (17), 5277-5289, 2012 | 67 | 2012 |
| Pharmacokinetics, optimal dosing, and safety of linezolid in children with multidrug-resistant tuberculosis: combined data from two prospective observational studies AJ Garcia-Prats, HS Schaaf, HR Draper, M Garcia-Cremades, J Winckler, ... PLoS medicine 16 (4), e1002789, 2019 | 65 | 2019 |
